Gilead Sciences Earnings: Here’s Why Investors Like These Results

Gilead Sciences Inc. (NASDAQ:GILD) delivered a profit and met Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are up 5.57%.

Gilead Sciences Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share were the same at $0.50 in the quarter as EPS of $0.50 in the year-earlier quarter.

Revenue: Rose 10.48% to $2.66 billion from the year-earlier quarter.

Actual vs. Wall St. Expectations: Gilead Sciences Inc. reported adjusted EPS income of $0.50 per share. By that measure, the company met the mean analyst estimate of $0.50. It missed the average revenue estimate of $2.66 billion.

Key Stats (on next page)…

Revenue increased 4.96% from $2.53 billion in the previous quarter. EPS increased 4.17% from $0.48 in the previous quarter.

Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.49 and has not changed. For the current year, the average estimate has moved down from a profit of $2.02 to a profit of $1.98 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]